Posts from December, 2016 - VAR2 Pharmaceuticals

The role of oncofetal CSA is published in a major article Thursday, 01 December 2016

Best poster presentation at EMBO Cancer meeting!

Uncategorized 19 September 2018

It is with great pleasure we can announce that Dr. Nader Al-Nakouzi was awarded The FEBS Journal Best Poster Prize for the poster "Expression and regulation of oncofetal chondroitin sulfate in prostat...

Presentation of VAR2-based immunotherapy at the 9th CDD Conference on Cancer

Uncategorized 16 September 2018

Co-founder and executive Chairman of the Board of directors, Dr. Mads Daugaard, are to present data on VAR2-based immunotherapy in the context of the cancer microenvironemnt at the 9th CDD Confer...

Presenting at EMBO Workshop Cellular signalling and cancer therapy, 14 – 18 September 2018

Uncategorized 13 September 2018

Our Research Scientist Dr. Nader Al-Nakouzi, will present new exciting data on oncofetal Chondrotin sulfat A in prostate cancer at the Cellular signalling and cancer therapy EMBO workshop, taking plac...

Nordic Life Science Days 2018

Uncategorized 10 September 2018

VAR2 Pharmaceuticals/VarCT Diagnostics will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business.